Skip to main content
Premium Trial:

Request an Annual Quote

Australia's Avoca Retains Top Spot as Fastest Life Science Supercomputer

Premium

NEW YORK (GenomeWeb) – In the 43rd edition of the Top500 list, released this week, "Avoca," the 65,536-core IBM BlueGene/Q supercomputer owned by Australia's Victorian Life Sciences Computation Initiative is still the fastest life science supercomputer in the world.

The system, which clocks in at 715.6 teraflops is now No. 57 on the list of the world's fastest supercomputers, down from the No. 48 spot it held in the November version of the twice-yearly ranking.

Avoca is the only life science system still ranked. Beagle, the 17,856-core, 125.8-teraflop Cray system housed at the University of Chicago's Computation Institute and the only other life science system that was included in the November list — it came in at No. 455 — is no longer ranked.

China's Tianhe-2, or Milky Way-2, developed by China's National University of Defense Technology, is still the fastest computer according to current rankings. The full list is available here.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.